Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized trial of amiodarone before electrical cardioversion in persistent atrial fibrillation
2023-507201-34-00Phase 4Authorised
- Sponsor
- Institut d'Investigació Sanitària Pere Virgili
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Institut d'Investigació Sanitària Pere Virgili. Primary endpoint: Reversion to sinus rhythm before electrical cardioversion. Planned start Aug 2024; status: authorised.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2023-507201-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507201-34-00.